Part D Price Controls: House Bill Flags Issue As Health Reform Moves Ahead
Executive Summary
A group of 61 House members is attempting to generate support for HHS drug price negotiations in Medicare Part D despite the fact that health care reform legislation is moving ahead in Congress without such a provision
You may also be interested in...
Obama Health Reform Plan Uses MA Cuts, Pharma Fees To Close Donut Hole
The Obama administration's proposal on health care reform would phase out the Medicare Part D coverage gap and pay for it through cuts to Medicare Advantage plans and with annual fees on branded biopharmaceutical companies
Closing Part D Gap May Be Among Senate Health Reform Bill Fixes
A plan to eliminate the Medicare Part D coverage gap is one of the measures House and Senate leaders continue to discuss as part of a package of changes to the Senate health reform bill that could be cleared through the budget reconciliation process, according to senior congressional staff
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011